Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.110
+0.160 (4.05%)
At close: Feb 21, 2025, 4:00 PM
4.150
+0.040 (0.97%)
After-hours: Feb 21, 2025, 5:52 PM EST
MRVI Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$10.28
Upside
+150.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $7 → $4.25 | Hold → Strong Sell | Downgrades | $7 → $4.25 | +3.41% | Dec 5, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $13 | Buy | Maintains | $17 → $13 | +216.30% | Nov 8, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2024 |
| Baird | Baird | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +118.98% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +70.32% | Oct 8, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $10 | Buy | Initiates | $10 | +143.31% | Aug 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $15 | Buy | Reiterates | $15 | +264.96% | Aug 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $11 → $10 | Buy → Hold | Downgrades | $11 → $10 | +143.31% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +94.65% | Aug 8, 2024 |
| UBS | UBS | Hold Maintains $8.5 → $11 | Hold | Maintains | $8.5 → $11 | +167.64% | Aug 8, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +70.32% | Jul 9, 2024 |
| Baird | Baird | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +143.31% | May 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +264.96% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +240.63% | Feb 23, 2024 |
| Stifel | Stifel | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +143.31% | Feb 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.